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Introduction: Pleomorphic adenoma accounts for 65 percent of all salivary gland tumors. It has been
identified in several anatomical regions, but pleomorphic adenoma arising in the ear canal, first described in
1951, is extremely rare.
Case presentation: A 40-year-old Japanese man’s left ear canal was obstructed by a pleomorphic adenoma
that caused mild conductive hearing loss. The tumor was resected and he remains disease-free two years
after surgery.
Conclusions: Pleomorphic adenoma usually arises from a major and minor salivary gland, but pleomorphic
adenoma of the ear canal is derived from the ceruminous gland. We discuss the present case and 37 other
case reports in our effort to clarify the clinical features and the course of pleomorphic adenoma in the
ear canal.
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Pleomorphic adenoma (PA) is a benign tumor that usu-
ally originates in a major salivary gland. It also arises
from minor salivary glands and other structures in the
head and neck region such as the lip and cheek [1]. PA
arising in the ear canal is very rare. Since the first
report of PA in the ear canal by Mark and Rothberg
in 1951 [2], there have been only a few similar case
reports. PA in the ear canal is derived primarily from
the ceruminous gland, the modified apocrine sweat gland
of the ear canal [3]. We report a case of PA arising in
the ear canal and provide a brief review of the relevant
literature.
Case presentation
A 40-year-old Japanese man presented at an Ear, Nose
and Throat clinic with left-side hearing loss and tinnitus
without otalgia or vertigo that had been present in the
prior 10 days. A tumor was identified at the opening of* Correspondence: maruyamaoto@gmail.com
Department of Otolaryngology, Tokyo Medical and Dental University,
Bunkyo-ku, Yushima 1-5-45, Tokyo 113-8519, Japan
© 2014 Maruyama et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.his left ear canal, and he was referred to our hospital.
The tumor was smoothly covered by the skin, and it was
not mobile. It obstructed his ear canal so that the tym-
panic membrane was hidden from view (Figure 1). The
pure tone audiogram showed mild conductive hearing
loss with an air-bone gap of 20 to 45dB. Computed to-
mography showed a homogeneous mass from the pos-
terior wall of his left ear canal without infiltration into
the other structures. In the ear canal, the area between
the tumor and the tympanic membrane was isodense
(Figure 2).
Considering these noninvasive findings, this tumor
was suspected to be benign. Surgical treatment under
general anesthesia was performed two months after the
start of symptoms. The tumor was resected en bloc via
a postaural and endaural approach with a margin in-
cluding cartilage and skin. A significant amount of hy-
perkeratotic substances were present behind the tumor,
apparently retained debris. The tympanic membrane wastral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Clinical features of the 40-year-old man at the first
visit: the pleomorphic adenoma tumor arises from the posterior
wall of his left ear canal.
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retroauricular skin flap and fascia temporalis were used
to cover the cutaneous defect of the ear canal.
The tumor size was 18×12×12mm. It was well cir-
cumscribed and its cut surface was whitish (Figure 3a).
Microscopically, the tumor showed a mixture of epithe-
lial cells with formed ducts and myxomatous stromaFigure 2 Computed tomography imaging: computed
tomography showing the left ear canal mass (white arrow).
The mass between the tumor and the tympanic membrane was
thought to be earwax.with spindle cells. It had a cartilage component. The
pathological diagnosis was PA (Figure 3b). The tumor
was sharply marginated, but its capsule was not formed
sufficiently, so that it invaded the surrounding fat tissue
in some places. The margin of the excision was clear.
Approximately two years after the tumor removal, there
was no stenosis of the ear canal or recurrence of the
tumor.Discussion
PA, a mixed tumor, accounts for 65 percent of all tu-
mors of the salivary glands [1]. They mostly arise from a
major salivary gland, but they can arise at other parts of
the head and neck, including the minor salivary glands
as well as the cheeks and eyelids. However, PA of the ear
canal is very rare. Kuo et al. reported 37 cases of PA
arising from sites other than the major salivary glands,
and only one of the 37 cases was observed in the ear
canal [1].
Since the first report of a PA arising in the ear canal
by Mark and Rothberg in 1951, there have been 37 simi-
lar cases reported in the English literature [1-10]. There
were 16 males and 16 females (the gender of the other
five cases was not mentioned) and their ages ranged
from 15 to 79 years (average 46.0 years) (Figure 4a). The
tumor sizes varied from 0.5 to 3.5cm. The sites in the
canal are presented in Figure 4b. The symptoms of PA
arising in the ear canal varied: hearing loss, otalgia, tin-
nitus, aural fullness, otorrhea, and sometimes no symp-
toms (Table 1). These symptoms were caused by the
obstruction of the ear canal by the tumor, as in cases
of benign tumors of the ear canal [11]. The duration
of symptoms before clinical presentation ranged from
10 days to 13 years. As with other benign tumors, the du-
ration of symptoms was often a period of years. The cases
were sometimes associated with chronic otitis media and
cholesteatoma [5,6].
Historically, PA of the ear canal was called cerumino-
ma, indicating glandular tumors of the ear canal regar-
dless of whether they were benign or malignant. Welti
classified these tumors into four groups: ceruminous ad-
enoma, adenoid-cystic carcinoma, ceruminous adenocar-
cinoma, and the most rare, pleomorphic adenoma [3].
Based on his classification, syringocystadenoma papil-
liferum has been added as a benign neoplasm arising
from the ceruminous gland [12]. The ceruminous gland
is the cerumen-secreting modified apocrine sweat gland
located in the cartilaginous portion of the ear canal. In
these tumors, it is important to distinguish malig-
nancy. Adenoid cystic carcinoma is the most commonly
reported primary ceruminous gland malignancy [13]. In-
vasiveness appears to be the only sign of malignancy,
but the symptoms do not always reflect the character
Figure 3 Resected tumor. (a) The tumor size was 18×12×12mm, and its cut surface was whitish. (b) Histological findings of the tumor showing
the glandular epithelial component and mixoid stroma.
Maruyama et al. Journal of Medical Case Reports 2014, 8:178 Page 3 of 5
http://www.jmedicalcasereports.com/content/8/1/178of tumors so Hicks recommended early excisional bi-
opsy [3,14]. At the same time, there is an opinion that
these tumors should be taken as potentially malignant
because the biopsy is not sufficiently reliable if it is
limited [13].Figure 4 The age range and tumor sites of similar cases. (a) The age rPA of the ear canal is characterized by the presence of
a subepithelial proliferation of glandular structures with
nests of myoepithelial components in a chondromyxoid
stroma, similar to the histology of PA of salivary gland
origin [12]. Myoepithelial cells of the ceruminous glandsange of 37 cases. (b) Tumor sites in the canal.

















*A case-associated cholesteatoma presented as facial palsy.
(Some cases had more than one symptom) [1-10]
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canal; they differentiate and can form a component of
the tumor [4].
En bloc surgical excision with a sufficient margin is
important in the treatment of PA of the EAC to prevent
recurrence. Recurrence occurs in approximately 5 per-
cent of PAs arising in the parotid gland after primary
surgery, caused by capsule rupture, a positive margin,
and tumor spillage [15]. Additionally, 3 to 4 percent of
PAs arising from a salivary gland may transform into
carcinoma ex-pleomorphic adenomas.
In contrast, the malignant transformation of a PA of
the ear canal has been reported only by Botha and Kahn,
as ‘aggressive chondroid syringoma’ [7]. Chondroid syrin-
goma is the term used in dermatological practice to de-
scribe PA from skin appendages [7,8]. In that case, the
tumor recurred with cellular atypism and mitotic activity
and accompanied several satellite nodules three years after
the first resection [7]. Another case of recurrence was
reported by Pahor et al.; it occurred because of incomplete
resection but showed no malignant transformation [9].
Postoperative radiotherapy for PA is controversial.
It has been reported as not effective and can induce
malignant change, although it has improved the local
control for patients with inadequate margins and/or
multinodular recurrence [10,15]. Because the effect of
radiotherapy may uncertain, it is best to try to avoid the
necessity for radiotherapy. A sufficient excision without
breaking the capsule is important for obtaining a good
prognosis and a long follow-up after surgery is necessary
to check for any recurrence.Conclusions
We describe a case of PA arising in the ear canal. PA of
the ear canal is very rare and it presents with various
symptoms. Surgical excision with sufficient margins and
a long follow-up are important in the treatment.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for




The authors declare that they have no competing interests.
Authors’ contributions
AM designed the clinical review, performed most of the work, did most
of the data analysis, and wrote most of the paper. TT helped with the
data analysis. KK performed the surgery, helped with the data analysis
and wrote parts of the paper. All authors read and approved the final
manuscript.
Received: 13 January 2014 Accepted: 11 March 2014
Published: 6 June 2014
References
1. Kuo YL, Tu TY, Chang CF, Li WY, Chang SY, Shiao AS, Chu PY, Chan KT,
Tai SK, Wang YF, Kao SC, Kao SY, Lo WL, Wu CH, Shu WH, Ma S, Wang TH:
Extra-major salivary gland pleomorphic adenoma of the head and neck:
a 10-year experience and review of the literature. Eur Arch
Otorhinolaryngol 2011, 268:1035–1040.
2. Mark I, Rothberg M: Mixed tumor of skin of external auditory canal.
AMA Arch Otolaryngol 1951, 53:556–559.
3. Hicks GW: Tumors arising from the glandular structures of the external
auditory canal. Laryngoscope 1983, 93:326–340.
4. Haraguchi H, Hentona H, Tanaka H, Komatuzaki A: Pleomorphic adenoma
of the external auditory canal: a case report and review of the literature.
J Laryngol Otol 1996, 110:52–56.
5. Tsukahara K, Suzuki M, Tokashiki R, Motohashi R, Iwaya K: Pleomorphic
adenoma of the external auditory canal complicated by hearing
loss secondary to chronic otitis media. Auris Nasus Larynx 2006,
33:183–186.
6. Nandi SP, Shaw HJ: Hidradenoma of the external auditory meatus
associated with facial palsy and chronic otitis media. J Laryngol Otol 1961,
75:992–996.
7. Botha JBC, Kahn LB: Aggressive chondroid syringoma. Report of a case in
an unusual location and with local recurrence. Arch Dermatol 1978,
114:954–955.
8. Mansor P, George MK, Pahor AL: Ceruminous gland tumors: a reappraisal.
J Laryngol Otol 1992, 106:727–732.
9. Pahor AL, O’Hara MD: Hidradenoma of the external auditory meatus.
(Review of the literature and report of a pleomorphic adenoma).
J Laryngol Otol 1975, 89:707–720.
10. Suzuki K, Baba S, Miyamoto N: Pleomorphic adenoma of the external
auditory canal in Japan, with a case report. Auris Nasus Larynx 1991,
18:271–279.
11. Nelms CR, Paparella MM: Early external auditory canal tumors.
Laryngoscope 1968, 78:986–1001.
12. Wenig BM: Benign ceruminous gland neoplasms. In Atlas of head and
neck pathology, Volume Volume. 2nd edition. Edited by Wenig BM.
Philadelphia: W. B. Saunders; 2008.
13. Crain N, Nelson BL, Barnes EL, Thompson LDR: Ceruminous gland
carcinomas: a clinical pathologic and immunophenotypic study of 17
cases. Head Neck Pathol 2009, 3:1–17.
Maruyama et al. Journal of Medical Case Reports 2014, 8:178 Page 5 of 5
http://www.jmedicalcasereports.com/content/8/1/17814. Bhagat S, Varshney S, Bist SS, Mishra S, Aggarwal V: Adenoid cystic
carcinoma of external auditory canal. Online J Health Allied Sci 2012,
11:19.
15. Mendenhall WM, Mendenhall CM, Werning JW, Malyapa RS, Mendenhall
NP: Salivary gland pleomorphic adenoma. Am J Clin Oncol 2008,
31:95–99.
doi:10.1186/1752-1947-8-178
Cite this article as: Maruyama et al.: Pleomorphic adenoma presenting
with conductive hearing loss in the ear canal: a case report and review
of the literature. Journal of Medical Case Reports 2014 8:178.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
